Skip to main content
Clinical Trials/NCT05787951
NCT05787951
Not yet recruiting
Not Applicable

Frequency and Risk Factors of Acute Myeloid Leukemia at Clinical Haemtology Unit of Assiut University Hospital

Assiut University0 sites200 target enrollmentStarted: May 1, 2023Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
200
Primary Endpoint
Frequency of acute myeloid leukemia at clinical Haemtology unit of Assiute university hospital

Overview

Brief Summary

  1. to assess the frequency of acute myeloid leukemia at clinical Haematology unit of Assiute university hospital
  2. to study correlations of known risk factors and if there are new risk factors participate in increasing frequency of acute myeloid leukemia

Detailed Description

Acute myeloid leukaemia (AML) is a rare heterogeneous disease comprising a group of hematopoietic neoplasms originating from the excessive clonal proliferation of myeloid pre- cursor cells [1]. Diagnosis of AML is based on morphological diagnosis with proliferation of blast cells ≥ 20% of bone marrow cells, flow cytometric analysis and cytogenetic abnormalities, including the t(8;21)(q22;q22), t(15;17) (q22;q12) and inv (16)(p13.1;q22) which are associated with longer remission and survival, while alterations of chromosomes 5, 7, complex karyotype and 11q23 are associated with poor response to therapy and shorter overall survival [2] The etiological agent and pathogenesis of AML are not entirely clear, only few AML cases can be accurately classified through traditional cellular morphological classification [3]It is the most common acute leukaemia in adults. It accounts for 1.3% of new cancer patients in the United States, in 2018[ 4] Some factors are well documented to increase the risk of some types of leukemia such as benzene exposure and ionizing radiation [5] increased frequency of acute myeloid leukemia has been noticed at Haematology unit so the aim of the study to assess the the frequency of acute myeloid leukemia and to evaluate the risk factors for it .

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult Patients(above 18 years) diagnosed as acute myeloid leukemia according to WHO diagnostic criteria

Exclusion Criteria

  • Patients with other types of leukemia

Outcomes

Primary Outcomes

Frequency of acute myeloid leukemia at clinical Haemtology unit of Assiute university hospital

Time Frame: Two years

Secondary Outcomes

  • Risk factors of acute myeloid leukemia at clinical Haemtology unit of Assiute university hospital(Two years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sanaa Ezzat Hussien

Sanaa Ezzat Hussien

Assiut University

Similar Trials